Tag Archive | "Alzheimer’s disease"

Novartis creates pharma alliance with Banner Alzheimer’s Institute

Tags: , ,


Novartis announced a pharma alliance with Banner Alzheimer's Institute on a pioneering clinical study in Alzheimer's disease (AD) prevention. Read the full story

Merck and Bionomics sign a pharma licensing deal for $526 million

Tags: , , ,


Bionomics has entered into an exclusive research collaboration and pharma licensing Agreement with Merck for its BNC375 research program targeting cognitive dysfunction associated with Alzheimer’s disease and other central nervous system conditions. Read the full story

Neurotez signs licensing deal for Leptin

Tags: , ,


Neurotez announced the execution of an exclusive license agreement covering its Leptin derivatives (Leptin Products), for the treatment of Alzheimer’s disease (AD) and other cognitive disorders, with GCA Therapeutics. Read the full story

Biogen Idec forms a pharma alliances with Proteostasis Therapeutics

Tags: , , ,


A pharma alliances is created between Biogen Idec and Proteostasis Therapeutics for Alzheimer's treatment. Read the full story

True North Therapeutics and iPierian in $30 million Series A financing round

Tags: , , ,


iPierian announced a Series A financing round of $30 million to advance iPierian’s drug development in neurodegenerative disease as well as launch a spin-out company, True North Therapeutics. Read the full story

AstraZeneca big pharma partners Tufts University for Neuroscience research

Tags: , , ,


AstraZeneca and Tufts University's School of Medicine and Sackler School of Graduate Biomedical Sciences are becoming pharma partners. Read the full story

Elan big biotech deals Speranza Therapeutics for ELND005 license

Tags: , , ,


Elan has entered biotech deals and decides to divest ELND005 to, Speranza Therapeutics, focused on progressing the development of ELND005 (Scyllo-inositol). Read the full story

Eli Lilly pharma deals with Siemens Medical Solutions for Alzheimer’s disease

Tags: , , ,


Big pharma company, Eli Lilly, pharma deals with Siemens Medical Solutions for the asset purchase of two investigational positron emission tomography tracers to be used in a diagnostic capacity for Alzheimer's disease. Read the full story

Alzheimer’s Disease Partnering

Tags: , ,


The Alzheimer's Disease Partnering provides understanding and access to the alzheimer's disease partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story

Findings from DiaGenic, Pfizer collaboration show promising early results

Tags: , ,


DiaGenic has reported preliminary positive findings from the collaborative R&D project with Pfizer Inc. where the objective is to identify blood-based biomarkers that may be useful in diagnosing and monitoring of Alzheimer’s Disease (AD). Read the full story